NASDAQ · Financial Statements
Phathom Pharmaceuticals, Inc. (PHAT) Financial Statements
$7.24
NASDAQ: PHAT
Market Cap $585.64M
Overview Financials Dividend Phathom Pharmaceuticals, Inc. most recently reported annual revenue of $175.0M, net profit of $-221.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $1.0M $55.0M $175.0M Operating Profit $-135.0M $-172.0M $-167.0M $-277.0M $-160.0M Net Profit $-144.0M $-198.0M $-202.0M $-334.0M $-221.0M EPS $-4.00 $-5.70 $-3.93 $-5.29 $-3.03 Op Margin — — -24532.5% -502.2% -91.4%
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $189.0M $165.0M $414.0M $378.0M $259.0M Total Liabilities $117.0M $240.0M $487.0M $632.0M $697.0M Cash $183.0M $155.0M $381.0M $297.0M $130.0M Borrowings $91.0M $97.0M $139.0M $202.0M $212.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-148.0M $-147.0M $-138.0M $-267.0M $-167.0M Investing Cash Flow $-1.0M $-2.0M $-3.0M $0 $0 Financing Cash Flow $2.0M $0 $173.0M $2.0M $-2.0M Net Cash Flow $-104.0M $-28.0M $228.0M $-84.0M $-167.0M Free Cash Flow $-149.0M $-148.0M $-139.0M $-267.0M $-167.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.03 EV / EBITDA -15.24 FCF Yield -6.66% Quick Ratio 1.87 Interest Coverage -0.64 Return 1Y 35.36% Return 3Y -14.26% Return 5Y -67.76%
Screens featuring this stock